A PHASE 1 TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PK, AND PD of AX-0810 IN HEALTHY PARTICIPANTS
PQ-0810-001
Phase 1 other active
Quick answer
A PHASE 1 TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PK, AND PD of AX-0810 IN HEALTHY PARTICIPANTS for Cholestatic liver disease is a Phase 1 program (other) at ProQR Therapeutics N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ProQR Therapeutics N.V.
- Indication
- Cholestatic liver disease
- Phase
- Phase 1
- Modality
- other
- Status
- active